Aggregated China Business Blogs



China Biotech in Review: Effective Collaboration Between US-Asian Companies and US Investors

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
November 19, 2007|

It was another significant week for investments in China biopharma. The week was headlined by the acquisition of a US-Korean medical device company, N Spine, which is not exactly a China biophama, but shows how effective a collaboration between a US-Asian company and US investors can be (see story).

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Biotech Week in Review: East-West Pharma Interaction
  • China Biotech Week in Review: East-West Pharma Interaction
  • China Biotech in Review: Broad Trends, Individual Companies
  • Biotech in Review: Positive Consolidation in China Life Science Companies
  • Earnings and More in China Biotech Weekly Review

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |